SCHEMBL29562048

SCHEMBL29562048

Cc1c(Oc2cc(F)cc(N)c2F)ccc([N+](=O)[O-])c1C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ GRM6 O15303 1/20 0.33
▸ AR P10275 4/20 0.32
▸ HPGD P15428 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ PGR P06401 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ HSPB1 P04792 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22832036 1.00 LMNA (0.35) LMNAPOLBSMN1; SMN2MAPTALDH1A1
SCHEMBL29561992 0.92 LMNA (0.35) LMNAPOLBSMN1; SMN2MAPTALDH1A1
SCHEMBL22831965 0.92 LMNA (0.35) LMNAPOLBSMN1; SMN2MAPTALDH1A1
SCHEMBL22831892 0.90 LMNA (0.40) LMNAPOLBSMN1; SMN2MAPTL3MBTL1
SCHEMBL29562065 0.90 LMNA (0.40) LMNAPOLBSMN1; SMN2MAPTL3MBTL1
SCHEMBL22832130 0.87 GRM6 (0.35) LMNAPOLBSMN1; SMN2MAPTALDH1A1
SCHEMBL29562072 0.87 GRM6 (0.35) LMNAPOLBSMN1; SMN2MAPTALDH1A1
SCHEMBL22832024 0.86 GRM6 (0.37) GRM6
SCHEMBL22832025 0.85 HSPB1 (0.34) LMNAPOLBSMN1; SMN2MAPTALDH1A1
SCHEMBL29562112 0.85 HSPB1 (0.34) LMNAPOLBSMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114026073-B Quinazolin-4-one derivatives for the treatment of BRAF related diseases and disorders ARRAY生物制药公司 2024-08-23 — — CN disclosed
EP-3990437-A1 QUINAZOLIN-4-ONE DERIVATIVES USEFUL FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS Array Biopharma, Inc. (US) 2022-05-04 — — EP disclosed
Send feedback